Search

everythinglearnresearchcommunity

for

Search:↓

A complex X chromosome rearrangement can increase the risk of multiple autoimmune diseases.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

A rare autoimmune condition, Satoyoshi syndrome, can start in adults and improve with immunosuppressive treatment.

Recognizing the link between certain autoimmune disorders and neurological conditions can improve diagnosis and treatment.

Alopecia areata is linked to autoimmune antibodies.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Autoimmune-related phenomena do not affect the progression or characteristics of lichen sclerosus in women.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.

Lacrimal gland inflammation and alopecia areata can happen together due to autoimmune issues.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Alopecia areata is an autoimmune condition causing patchy hair loss, with treatments focusing on immune system regulation and hair regrowth.

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Autoimmune conditions can be linked to trichoepitheliomas, with treatment focusing on cosmetic concerns.

Autoimmune myopathy may be linked to hair loss and skin depigmentation.